T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma.
Vincent-Salomon
A
A
Department of Tumor Biology, Institut Curie, Paris, France.
Mathiot
C
C
Macintyre
E
E
Girre
V
V
Fourquet
A
A
Mercier
C
C
Fréneaux
P
P
Dumont
J
J
Decaudin
D
D
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology / Q000473:pathology*; D016393:Lymphoma, B-Cell / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D000069283:Rituximab; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000473:pathology*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab